NYSE, SEE #New Order #Senior Notes SEE Announces Expiration and Results of Offer to Purchase 4.500% Senior Notes due 2023 January 27, 2023 18:51 EST CHARLOTTE, N.C.–(BUSINESS WIRE)–Sealed Air Corporation (“Sealed Air”) (NYSE: SEE) today announced that the previously announced cash tender offer (the “Tender Offer”) for any and all of its 4.500% senior notes due 2023 (the “Notes”) expired at 5:00 p.m. New York City time, on January 27, 2023 (the “Expiration Date”). No Comments
NASDAQ, PLRX #New Order #Private Placement Closed #Trending News Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares January 27, 2023 16:03 EST SOUTH SAN FRANCISCO, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the closing of its previously announced upsized underwritten public offering of 9,583,334 shares of its common stock, No Comments
NYSE, SEE #New Order SEE Announces the Total Consideration For Its Offer to Purchase 4.500% Notes Due 2023 January 27, 2023 15:23 EST CHARLOTTE, N.C.–(BUSINESS WIRE)–Sealed Air Corporation (“Sealed Air”) (NYSE: SEE) today announced the total consideration (the “Total Consideration”) relating to its previously announced cash tender offer (the “Tender Offer”) for any and all of its 4.500% senior notes due 2023 (the “Notes”) is €1,005.60 for each €1,000 principal amount of No Comments
JSPR, NASDAQ #New Order #Private Placement Closed #Syndromes Jasper Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 27, 2023 13:10 EST REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell No Comments
BTB, NASDAQ #Crypto #Featured #New Order #Trending News Bit Brother Increased Its Investment in Blockchain Field and Entered Brokerage Agreement to Purchase 400 Mining Rigs with Estimated Hash Rate of 40,000 TH/S January 27, 2023 10:00 EST CHANGSHA, China, Jan. 27, 2023 /PRNewswire/ — Bit Brother Limited (the “Company,” “we”, “BTB” or “Bit Brother”) (NASDAQ: BTB), through its subsidiary Bit Brother New York Inc (“BTB NY”), entered into brokerage agreement with Blockworx1, LLC to purchase 400 S19J Pro cryptocurrency mining servers . All 400 servers are No Comments
NASDAQ, OXLC, OXLCL, OXLCM, OXLCN, OXLCO, OXLCP, OXLCZ #Dividends #Financial Data #New Order #Shares Release Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Third Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending April, May, and June 2023 January 27, 2023 08:00 EST GREENWICH, Conn., Jan. 27, 2023 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On January 26, 2023, our Board No Comments
NASDAQ, WLDS, WLDSW #New Order #Trending News #Upcoming Presentation Wearable Devices Selected to Present at Best of CES 2023 January 27, 2023 07:00 EST The company was invited to present at the event highlighting trends and products from CES 2023 at The Paley Center for Media in New York City YOKNEAM ILLIT, ISRAEL, Jan. 27, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices”), a growth company developing a non-invasive No Comments
BRSF, OTC #New Order #New Partnership Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel January 26, 2023 10:17 EST LAKEWOOD RANCH, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific (OTCQB:BRSF), a Florida-based applied science technology company, today announces a new distribution agreement with SysteMedic to meet market demand. Brain Scientific is targeting the pediatric and ICU markets for the NeuroCap in hospitals. SysteMedic plans No Comments
NASDAQ, NMRD #New Order #Trending News Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet January 26, 2023 09:57 EST LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, today announced receipt of a first purchase order for 5,000 proBEAT™ subscriptions from HealthFleet Inc. (“HealthFleet”), a leading telehealth No Comments
DSX, NYSE #New Order Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for m/v Atalandi and a New Time Charter Contract for m/v Leto January 26, 2023 09:20 EST ATHENS, Greece, Jan. 26, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has extended the time charter contract with Aquavita International S.A., No Comments
STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace) 01/23/2023
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress 01/23/2023